Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × Lenalidomide × 90 days × Clear all

Sponsor

Conditions

Multiple Myeloma 73 Lymphoma, Follicular 20 Lymphoma, Large B-Cell, Diffuse 14 Lymphoma, B-Cell, Marginal Zone 10 Recurrence 8 Lymphoma 8 Neoplasms, Plasma Cell 7 Lymphoma, Non-Hodgkin 7 Lymphoma, Mantle-Cell 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Neoplasms 4 Neoplasm, Residual 3 Myelodysplastic Syndromes 3 Lymphoma, B-Cell 3 Smoldering Multiple Myeloma 2 Leukemia, Myelomonocytic, Chronic 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Plasmacytoma 1 Paraproteinemias 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Lymphoproliferative Disorders 1

Interventions

Magnetic Resonance Spectroscopy 5 Biopsy 4 X-Rays 3 Specimen Handling 3 Phantoms, Imaging 3 Nuclear Medicine Department, Hospital 3 selpercatinib 2 erdafitinib 2 entrectinib 2 ensartinib 2 Radiotherapy 2 Nivolumab 2 Lomustine 2 Etoposide 2 Cyclophosphamide 2 Carboplatin 2 ulixertinib 1 tipifarnib 1 tazemetostat 1 regorafenib 1 perillyl alcohol 1 pemigatinib 1 pembrolizumab 1 pegfilgrastim 1 palbociclib 1 olaparib 1 niraparib 1 lenvatinib 1 larotrectinib 1 ivosidenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡